Latest news

23-Jul-2010
Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®[1]

20-Jul-2010
Novartis receives approval in China for Rasilez, a first-in-class direct renin inhibitor for high blood pressure, the leading preventable cause of death in China

15-Jul-2010
Novartis delivers strong financial performance in second quarter, underpinned by increased momentum in innovation

View all press releases

 

 

Stay connected

Sign up for email alerts

Learn more about RSS feeds and how to subscribe

English newsfeed

German newsfeed

French newsfeed

Follow Novartis on Twitter